European Approval of Experimental COVID-19 Replicon mRNA Injections Is a Grave Mistake
Global Research » Europe 2025-02-23
Summary:
Last week, CSL and Arcturus Therapeutics announced that the European Commission has approved KOSTAIVE® (ARCT-154), a COVID-19 self-amplifying (replicon) mRNA injection, for individuals 18 and older. It is the first replicon shot approved by the European Commission and is …
The post European Approval of Experimental COVID-19 Replicon mRNA Injections Is a Grave Mistake appeared first on Global Research.